Amneal Pharmaceuticals (AMRX) PT Raised to $11 at Barclays
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $18.13 -0.11%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Amneal Pharmaceuticals (NASDAQ: AMRX) to $11.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
